Program:
09.00 Welcome
09.15 - 10.45 Morning session 1
Colon tumor pathogenesis – stem cells - Louis Vermeulen (NL)
CIN – cGAS-STING – driving metastasis - Samuel Bakhoum (US)
11.15 - 12.45 Morning session 2
Minimal residual disease – ctDNA - Claus Andersen (DK) Combination treatment benefit in CRC - Lodewyk Wessels (NL)
14.00 - 16.15 Afternoon session
Pre-clinical drug testing in organoids - Nicola Valeri (UK)
WGS in research and clinical practice - Edwin Cuppen/Kris Samsom (NL) PLCRC – real CRC patients, real life data - Miriam Koopman (NL)
16.15 - 18.00 Closure and Drinks
Admission is free, but please register here.